BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2023

Dec 22, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2023-12-21

Reporting Person: BIENAIME JEAN JACQUES (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-12-21	Common Stock	M	10000	$63.10	Acquired	435112	Direct
2023-12-21	Common Stock	S	10000	$93.99	Disposed	425112	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-12-21	Stock Option (Right to Buy Common Stock)	$63.10	M	10000	Disposed	2024-06-03	Common Stock (10000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	247333	Indirect
Common Stock	100	Indirect
Common Stock	100	Indirect

Footnotes

F1: Trade made pursuant to a 10b5-1 plan executed on August 7, 2023.

F2: Reflects the number of options outstanding after the transactions from this specific stock option grant.